Walgreens takes HIMSS' first Digital Health Innovation Award

The Personal Connected Health Alliance (PCHA) presented Walgreens with its first Digital Health Innovation Award for being the first retail pharmacy to launch mobile telemedicine strategies.

Adam Pellegrini, Walgreens divisional vice president of digital health, accepted the award at the 7th annual mHealth Summit.

At Walgreens, Pellegrini leads the development of new products and services that drive medication adherence with digital innovations around mHealth, wearables, telemedicine and remote monitoring. His team at Walgreens has been recognized by Forbes as the leaders in Digital Health for 2014, and helped create a digital platform, Balance Rewards for healthy choices, rewarding healthy habits.

"Walgreens digital health team, spearheaded by Adam, has been a leader in creating and deploying industry-setting mobile experiences, and is a pioneer in the use of innovative mobile and connected health technologies to improve the health and wellness of Walgreens customers," said Rich Scarfo, vice president, Personal Connected Health Alliance at HIMSS, and director of the mHealth Summit. "We could think of no better or more deserving team to receive our first Digital Health Innovation Award."

Walgreens' Balance Rewards for healthy choices is the largest connected health platform with more than 800,000 participants and over 400,000 connected devices and apps. This team also established the first-of-its-kind relationship between WebMD and Walgreens offering digital coaching at no cost, as well as the first connected device application that seamlessly finds and connects to the Walgreens Bluetooth-enabled blood pressure and blood glucose monitoring devices.

 

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.